Share this postSnowball ResearchEpizyme (EPZM): Small-cap company attracts former top executive of a pharma company that was sold for $5 billionCopy linkFacebookEmailNotesMoreEpizyme (EPZM): Small-cap company attracts former top executive of a pharma company that was sold for $5 billionApr 27, 2024∙ PaidShare this postSnowball ResearchEpizyme (EPZM): Small-cap company attracts former top executive of a pharma company that was sold for $5 billionCopy linkFacebookEmailNotesMoreShareEpizyme (EPZM) - Aug 2021616KB ∙ PDF fileDownloadDownload This post is for paid subscribersSubscribeAlready a paid subscriber? Sign inPreviousNext